TPA production in mice
Integrated Genetics and NIH announced Oct. 26 the production of the clot-dissolving agent in the milk of mice through the introduction of human and mouse genetic material in the animal. "This is the first published report in which a research team . . . has induced animals to produce a biologically active human therapeutic protein in their milk," the biotech firm said. Researchers plan to further test the potentially economical production method in larger animals such as goats and cows.
You may also be interested in...
France plans to begin issuing manufacturing quality certificates so firms can import ordinary cosmetics into China without animal testing under a 2020 draft regulation. The Personal Care Products Council is working to find a comparable solution for US manufacturers.
The calcineurin inhibitor, only the second drug to be approved by the US FDA for lupus nephritis, will be competing against GlaxoSmithKline’s Benlysta.
Federal prosecutors’ latest criminal case alleging fraudulent advertising and sales of vitamins and other nutrients available nonprescription in the US as remedies for infections from the novel coronavirus is against Johnny Stine, owner and operator of North Coast Biologics in Seattle.